I just want to finish up by saying the current Tricare contract with Express scripts expires in 2029, and DoD right now is in the acquisition planning phase for the next generation contract as it builds the requirements for this new contract. DoD cannot continue to ignore this conflict of interest that arises when a company owns both a pbm and a pharmacy. That has got to stop. And in the meantime, existing contracts should be regularly audited and subjected to much greater transparency to try to beat this kind of conflict out of the system. (07:50–08:03)
CLAIM
Asserts that there is a conflict of interest when a company owns both a pharmacy benefit manager and a pharmacy, which the DoD should not ignore.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
